Inventor · disambiguated record
Mark Ma
Also filed as: MA MARK · MA MARK Z · MA MARK ZHIQING
4 granted patents·7 pending applications·3 citations·filing 2012–2023
58Inventor score
Files withBIOSION INC5ALEXION PHARMA INC4CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD1UNIV MARYLAND1
Top patents by PatentIndex Score
11 records- 0175US10036747B2Lambodies with high affinity and selectivity for glycans and uses thereforUNIV MARYLAND·Filed 2012·Granted Jul 31, 2018·3 cites·15 claims
- 0258US2025109212A1Recombinant fusion protein targeting cd40 and cd47BIOSION INC·Filed 2023·Application pending·0 cites
- 0353US2025250355A1Antibodies targeting sirp-alpha and uses thereofBIOSION INC·Filed 2023·Application pending·0 cites
- 0451US12503517B2Antibodies binding CD40 and uses thereofBIOSION INC·Filed 2021·Granted Dec 23, 2025·0 cites·19 claims
- 0550US2023105029A1Antibodies binding il4r and uses thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
- 0648US2023383007A1Nanobodies binding trop2 and uses thereofBIOSION INC·Filed 2021·Application pending·0 cites
- 0746US2023414654A1Methods of treating copper metabolism-associated diseases or disordersALEXION PHARMA INC·Filed 2021·Application pending·0 cites
- 0846US2022334135A1Methods of measuring copper concentration in biological samplesALEXION PHARMA INC·Filed 2020·Application pending·0 cites
- 0942US2023331848A1Pd-1 binding antibodies and uses thereofBIOSION INC·Filed 2021·Application pending·0 cites
- 1041US11965884B2Method of quantitating unbound C5 in a sampleALEXION PHARMA INC·Filed 2017·Granted Apr 23, 2024·0 cites·9 claims
- 1137US11828683B2Method of quantitating unbound C5a in a sampleALEXION PHARMA INC·Filed 2017·Granted Nov 28, 2023·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →